{"entity":{"id":"sascha-dietrich","kind":"person","name":"Sascha Dietrich","aka":[],"tldr":"Haematologist-oncologist and Deputy Medical Director at University Hospital Düsseldorf, known for drug-response profiling in lymphoma and leukaemia.","summary":"Sascha Dietrich is Deputy Medical Director on the board of Universitätsklinikum Düsseldorf and a professor of haematology and oncology who directs the hospital's Department of Haematology, Oncology and Clinical Immunology. His research uses ex vivo drug perturbation and multi-omic profiling to guide precision therapy in lymphoid malignancies such as chronic lymphocytic leukaemia and hairy cell leukaemia. He is active in the CIO Düsseldorf cancer centre.","asOf":"2026-09-10","links":[{"label":"Institution profile","url":"https://www.uniklinik-duesseldorf.de/ueber-das-ukd/unternehmen/vorstand"},{"label":"PubMed","url":"https://pubmed.ncbi.nlm.nih.gov/?term=Dietrich+S%5BAuthor%5D+lymphoma"}],"tags":["leadership","clinician-scientist","haematology","lymphoma"],"related":[],"cancers":["cll","hairy-cell-leukemia","dlbcl"],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":["uk-duesseldorf"],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"role":"Deputy Medical Director","institutionId":"uk-duesseldorf","specialisms":["Haematology","Lymphoma","Functional precision oncology"],"profiles":[{"label":"Institution profile","url":"https://www.uniklinik-duesseldorf.de/ueber-das-ukd/unternehmen/vorstand"},{"label":"PubMed","url":"https://pubmed.ncbi.nlm.nih.gov/?term=Dietrich+S%5BAuthor%5D+lymphoma"}],"papers":[{"title":"Recurrent CDKN1B (p27) mutations in hairy cell leukemia","journal":"Blood","year":2015,"doi":"10.1182/blood-2015-04-643361"},{"title":"Ex vivo drug response profiling for response and outcome prediction in hematologic malignancies: the prospective non-interventional SMARTrial","journal":"Nature Cancer","year":2023,"doi":"10.1038/s43018-023-00645-5"},{"title":"Venetoclax synergizes with gilteritinib in FLT3 wild-type high-risk acute myeloid leukemia by suppressing MCL-1","journal":"Blood","year":2022,"doi":"10.1182/blood.2021014241"}]},"route":"/people/sascha-dietrich/","neighbours":{"cancer":[{"id":"cll","kind":"cancer","name":"Chronic lymphocytic leukaemia","route":"/cancers/cll/"},{"id":"dlbcl","kind":"cancer","name":"Diffuse large B-cell lymphoma","route":"/cancers/dlbcl/"},{"id":"hairy-cell-leukemia","kind":"cancer","name":"Hairy cell leukaemia","route":"/cancers/hairy-cell-leukemia/"}],"institution":[{"id":"uk-duesseldorf","kind":"institution","name":"University Hospital Düsseldorf / CIO Düsseldorf","route":"/institutions/uk-duesseldorf/"}]}}